[PDF][PDF] 疏血通联合依那普利对老年慢性心力衰竭患者血清N 末端钠尿肽前体水平, 血液流变学与心功能的影响

印红梅, 李春杰, 赵洋, 段颖, 何献超… - 现代生物医学 …, 2018 - biomed.cnjournals.com
摘要目的: 探讨疏血通联合依那普利老年慢性心力衰竭患者血清N 末端钠尿肽前体水平,
血液流变学与的影响. 方法: 选择2015 年5 月到2017 年5 月我院接诊的老年慢性心力衰竭患者 …

Adding a second bronchodilator in COPD: A meta-analysis on the risk of specific cardiovascular serious adverse events of tiotropium/olodaterol fixed-dose …

P Rogliani, BL Ritondo, B Zerillo… - COPD: Journal of …, 2020 - Taylor & Francis
Dual bronchodilation therapy represents the cornerstone for the treatment of COPD. A large
retrospective study reports that adding a second long-acting bronchodilator in patients with …

Evaluation of immunomodulatory mediators in chronic obstructive pulmonary disease and cardiovascular disease

Y Sun - 2022 - repository.cam.ac.uk
Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) are
among the leading causes of mortality and poor health burden in the world. Both COPD and …

Overdiagnosis and treatment of COPD in nonagenarians

M Tole, CJ Ascoli, M Joo, I Rubinstein - medRxiv, 2022 - medrxiv.org
Background The prevalence of COPD is increasing with age. However, the effects of age-
dependent decline in lung function on diagnosis and treatment of COPD in nonagenarians …

Urgencias cardiovasculares en pacientes con diagnóstico de diabetes y de Novo en una IPS de Magangué (Bol) entre enero del 2021 y julio 2023

WA Baleta Plata, BD Hernández Nieto - 2023 - bonga.unisimon.edu.co
La relación entre la diabetes y el riesgo cardiovascular se ha estudiado ampliamente; la
mortalidad asociada a la entre estas dos entidades sigue siendo un problema clínico y de …

[引用][C] Chronic Lung Disease and the Risk of Cardiovascular Disease: Based on Two Chinese National Prospective Cohort Studies

X Ren, S Wang, J Lian, C Pan, B Li, Y He, J Zhao… - 2022

The clinical symptoms, quality of life and laboratory indexes of newly diagnosed chronic obstructive pulmonary disease with hypertension.

MAO Yanqing, W Ya'nan, LI Jie - Journal of Practical …, 2024 - search.ebscohost.com
Objective We tried to investigate the difference of respiratory symptoms, quality of life, blood
routine examination and bone metabolism in patients with newly diagnosed chronic …

The heart-lung dilemma in COPD: a tale of two cities

JL López-Campos, LC Hernández… - Archivos de …, 2019 - pubmed.ncbi.nlm.nih.gov
The Heart-Lung Dilemma in COPD: A Tale of Two Cities The Heart-Lung Dilemma in COPD: A
Tale of Two Cities Arch Bronconeumol (Engl Ed). 2019 Apr;55(4):185-186. doi: 10.1016/j.arbres.2018.10.006 …

[PDF][PDF] Клінічно-патогенетичні особливості та лікування ішемічної хвороби серця у поєднанні з хронічним обструктивним захворюванням легень та ожирінням

ІЛ Неміш - 2022 - nauka.bsmu.edu.ua
Untitled Page 1 Page 2 2 АНОТАЦІЯ Неміш ІЛКлінічно-патогенетичні особливості та
лікування ішемічної хвороби серця у поєднанні з хронічним обструктивним …

Safety of bronchodilator reversibility test in elderly subjects: a prospective study

A Dor-Wojnarowska, A Parużyńska, A Kulczak… - … in Dermatology and …, 2021 - termedia.pl
Safety of bronchodilator reversibility test in elderly subjects: a prospective study Page 1
Advances in Dermatology and Allergology 2, April/2021 256 This is an Open Access article …